Scale Biosciences Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
64
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$52.7M
Scale Biosciences General Information
Description
Developer of a single-cell sequencing technology designed to offer scalable sample indexing, cell throughput, and multi-omics analysis. The company's technology offers patented split-pool barcoding and combinatorial indexing library preparation methods that leverage the cell as a compartment, enabling researchers to have access to a broad range of genomic, epigenomic, transcriptomic, proteogenomic, and multi-omic applications.
Contact Information
Website
www.scale.bio(Operating Subsidiary)
Corporate Office
- 3210 Merryfield Row
- San Diego, CA 92121
- United States
Corporate Office
- 3210 Merryfield Row
- San Diego, CA 92121
- United States
Scale Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 11-Aug-2025 | $52.7M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 24-Jul-2020 | Completed | Startup |
Scale Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Scale Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Scale Biosciences Patents
Scale Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202412627-D0 | Particle-based spatial hash-tagging method | Pending | 28-Aug-2024 | ||
| WO-2026035501-A1 | Particle-based spatial hash-tagging method | Pending | 08-Aug-2024 | ||
| US-20260028752-A1 | Methods and compositions for spatially-resolved single cell sequencing | Pending | 06-Apr-2023 | ||
| WO-2024211058-A1 | Methods and compositions for spatially-resolved single cell sequencing | Inactive | 06-Apr-2023 | ||
| EP-4642573-A1 | Single cell combinatorial indexing | Pending | 28-Dec-2022 | C12Q1/6869 |
Scale Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Scale Biosciences Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | ||
| Tao Capital Partners | Family Office | Minority |
Scale Biosciences FAQs
-
When was Scale Biosciences founded?
Scale Biosciences was founded in 2020.
-
Where is Scale Biosciences headquartered?
Scale Biosciences is headquartered in San Diego, CA.
-
What is the size of Scale Biosciences?
Scale Biosciences has 64 total employees.
-
What industry is Scale Biosciences in?
Scale Biosciences’s primary industry is Biotechnology.
-
Is Scale Biosciences a private or public company?
Scale Biosciences is a Private company.
-
What is the current valuation of Scale Biosciences?
The current valuation of Scale Biosciences is .
-
What is Scale Biosciences’s current revenue?
The current revenue for Scale Biosciences is .
-
How much funding has Scale Biosciences raised over time?
Scale Biosciences has raised $32.2M.
-
Who are Scale Biosciences’s investors?
ARCH Venture Partners and Tao Capital Partners have invested in Scale Biosciences.
-
When was Scale Biosciences acquired?
Scale Biosciences was acquired on 11-Aug-2025.
-
Who acquired Scale Biosciences?
Scale Biosciences was acquired by 10x Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
